相关实验视频

Updated: Jun 9, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

分子指标区分多药耐药结核病与药物敏感性结核病以及潜在的治疗药物

Shulin Song^1,2, Donghui Gan², Di Wu²

¹Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, 530023, Guangxi, China.

Molecular biotechnology

|October 24, 2024

概括

这项研究确定了A4GALT和S1PR1作为多抗药结核病 (MDR-TB) 诊断的潜在生物标志物. 研究人员还发现了九种潜在的药物,包括维拉帕米尔,用于治疗MDR-TB.

科学领域:

基因组学和生物信息学
免疫学免疫学免疫学
计算生物学计算生物学

背景情况:

多重耐药结核病 (MDR-TB) 构成了全球健康的重大威胁.
目前对耐药结核病 (DR-TB) 的诊断往往耗时且资源密集.
快速识别MDR-TB对于有效的治疗和控制至关重要.

研究的目的:

确定新的分子生物标志物,以区分MDR-TB和耐药结核病 (DS-TB).
通过计算分析来探索MDR-TB的潜在治疗剂.

主要方法:

对GSE147689数据集的差异基因表达分析,以确定关键基因.
应用机器学习算法 (随机森林,决策树,SVM-RFE) 来确定顶级生物标志物候选人.
使用GSE147690数据集验证已识别的生物标志物 (A4GALT,S1PR1).
免疫细胞透分析和与枢纽基因的相关性研究.
连接地图分析用于药物重用.

主要成果:

确定了117个差异表达基因 (DEG),主要涉及免疫反应途径.
A4GALT和S1PR1成为区分MDR-TB和DS-TB的显著分子标志物,其AUC值为0.881 (训练) 和0.7551 (测试).
多抗药性结核病样本显示出不同的免疫细胞概况,包括增加的T辅助1细胞和减少的激活树突细胞.
包括维拉帕米尔在内的9种潜在药物被确定为MDR-TB治疗的候选药物.

结论:

作为MDR-TB的诊断生物标志物,A4GALT和S1PR1显示出有希望的结果.
这项研究为开发更快的诊断工具和针对MDR-TB的新型治疗策略提供了基础.
了解MDR-TB的免疫细胞动态可以为治疗方法提供信息.

关键词:

生物标志物生物标志物药物药物药物药物药物免疫系统的透.机器学习是机器学习.多抗药结核病多抗药性结核病

更多相关视频

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Methods of Classification and Identification

Methods of Classification and Identification

Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: